A phase IV study to determine the safety and efficacy of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity in German-Austrian patients.
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2015
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record